Skip to main content
SpringerLink
Log in

A mouse hepatotropic variant of influenza virus

  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

A hepatotropic variant of avian influenza virus A/Turkey/England 63 (Hav 1, Nav 3) was selected by serial passages in mouse liver. Adaptation to this organ was established after 13in vivo passages and was found to improve during further passages as shown by increasing rates of replication in livers of ICR mice. The mutant virus finally selected was stable and differed from the original virus mainly in lethality upon intraperitoneal injection in mice, in its ability to grow to high titers in livers of susceptible animals and in plaque morphology in chick embryo fibroblasts. No differences were detected in hemagglutination inhibition and neutralization by standard mouse antisera. Pathogenicity for the liver was independent of the route of inoculation, included other laboratory animals sensitive to influenza virus and could be inhibited by amantadine. Fatal hepatitis in 50 per cent of susceptible mice by the intraperitoneal route required from 10 to 20 EID50. Pathological changes consisted of severe necrosis of liver parenchyma accompanied by release of F antigen into the serum and were apparently due to virus replication in hepatic cells as evidenced by immunofluorescence.

The main implications of this animal model for studies on experimental hepatitis and on myxovirus-host interactions in an organ not usually associated with influenza are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bingen-Brendel, A., Batzenschlager, A., Gut, J.-P., Hirth, C., Vetter, J. M., Kirn, A.: Etude histologique et virologique de l'hépatite dégénérative aigue provoquée par le FV 3 (frog virus 3) chez la souris. Ann. Inst. Pasteur122, 125–142 (1972).

    Google Scholar 

  2. Burch, G. E., Tsui, C. Y., Harb, J. M.: Hepatitis in mice infected with Coxsackie virus B1. Brit. J. exp. Path.54, 249–254 (1973).

    Google Scholar 

  3. Davies, W. L., Grunert, R. R., Haff, R. F., McGahen, J. W., Neumayer, E. M., Paulshock, M., Watts, J. C., Wood, T. R., Hermann, E. C., Hoffmann, C. E.: Antiviral activity of 1-adamantanamine (amantadine). Science144, 862–863 (1964).

    Google Scholar 

  4. Davies, W. L., Grunert, R. R., Hoffmann, C. E.: Influenza virus growth and antibody response in amantadine-treated mice. J. Immunol.95, 1090–1094 (1966).

    Google Scholar 

  5. DeLay, P. D., Casey, H. L., Tubiash, H. S.: Comparative study of fowl plague virus and a virus isolated from man. Publ. Health Reports82, 615–620 (1967).

    Google Scholar 

  6. Fravi, G., Lindenmann, J.: Induction by allogeneic extracts of liver-specific precipitating autoantibodies in the mouse. Nature218, 141–143 (1968).

    Google Scholar 

  7. Friedewald, W. F., Hook, E. W.: Influenza virus infection in the hamster. A study of inapparent virus infection and virus adaptation. J. exp. Med.88, 343–353 (1948).

    Google Scholar 

  8. Gerber, A., Sauter, C., Lindenmann, J.: Fowl plague virus adapted to human epithelial tumor cells and human myeloblastsin vitro. I. Characteristics and replication in monolayer cultures. Arch. ges. Virusforsch.40, 137–151 (1973).

    Google Scholar 

  9. Gerber, A., Sauter, C., Lindenmann, J.: Fowl plague virus adapted to human epithelial tumor cells and human myeloblastsin vitro. II. Replication in human leukemic myeloblast cultures. Arch. ges. Virusforsch.40, 255–264 (1973).

    Google Scholar 

  10. Grunert, R. R., McGahen, J. W., Davies, W. L.: Thein vivo antiviral activity of 1-adamantanamine (amantadine). I. Prophylactic and therapeutic activity against influenza viruses. Virology26, 262–269 (1965).

    Google Scholar 

  11. Haller, O., Bucher-Nurminen, A., Lindenmann, J.: Early events in myxovirus replication: immunofluorescent spots. Arch. Virol.47, 269–277 (1975).

    Google Scholar 

  12. Haller, O., Lindenmann, J.: Host-cell antigen potentiated by incomplete growth cycle of influenza virus. J. Natl. Cancer Inst.54, 459–464 (1975).

    Google Scholar 

  13. Henle, W., Henle, G.: Studies on the toxicity of influenza viruses. II. The effect on intra-abdominal and intra-venous injection of influenza viruses. J. exp. Med.84, 639–660 (1946).

    Google Scholar 

  14. Hoyle, L.: “The Influenza Viruses”, Virology Monographs 4. Stuttgart: Springer, 1968.

    Google Scholar 

  15. Levaditi, C., Haber, P.: Recherches sur le virus de la peste aviaire pathogène pour la souris. Ses affinités pour les néoplasmes. Rev. Immunol.3, 5–24 (1937).

    Google Scholar 

  16. Lindenmann, J., Lane, C. A., Hobson, D.: The resistance of A2G mice to myxoviruses. J. Immunol.90, 942–951 (1963).

    Google Scholar 

  17. Lindenmann, J., Klein, P. A.: Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus. J. exp. Med.126, 93–108 (1967).

    Google Scholar 

  18. McGahen, J. W., Hoffmann, C. E.: Influenza infections of mice. I. Curative activity of amantadine HCl. Proc. Soc. exp. Biol. Med.129, 678–681 (1968).

    Google Scholar 

  19. Mims, C. A.: Rift valley fever virus in mice. VI. Histological changes in the liver in relation to virus multiplication. Austr. J. exp. Biol. Med. Sci.35, 595–604 (1957).

    Google Scholar 

  20. Mims, C. A.: Aspects of the pathogenesis of virus diseases. Bact. Rev.28, 30–71 (1964).

    Google Scholar 

  21. Mims, C. A.: An analysis of the toxicity for mice of influenza virus. II. Intravenous toxicity. Brit. J. exp. Path.41, 593–598 (1960).

    Google Scholar 

  22. Oxford, J. S., Logan, I. S., Potter, C. W.:In vivo selection of an influenza A2 strain resistant to amantadine. Nature226, 82–83 (1970).

    Google Scholar 

  23. Pereira, H. G., Tumova, B., Law, V. G.: Avian influenza A viruses. Bull. WHO32, 855–860 (1965).

    Google Scholar 

  24. Radwansky, Z.: Pathomorphology of experimental influenza. II. Liver. Acta Med. Pol.X, 353–362 (1969).

    Google Scholar 

  25. Rosenmund, A.: Ein leberspezifisches Antigen im Serum von Leberkranken. Schweiz. Med. Wschr.101, 1023–1026 (1971).

    Google Scholar 

  26. Sauter, Ch., Bächi, Th., Lindenmann, J.: Human mammary carcinoma cell line: susceptibility to infection by an avian myxovirus. Europ. J. Cancer11, 59–63 (1975).

    Google Scholar 

  27. Smith, J. B., Iverson, G. M.: Occurrence of liver-specific antigen in adult human serum. Clin. exp. Immunol.13, 209–212 (1973).

    Google Scholar 

  28. Spigland, I., Grose, C.: Hepatitis associated with influenza A0 (Hong-Kong) infection. Abstr. Ann. Meeting Amer. Soc. Microbiol., Miami Beach, February 1973, p. 216.

  29. Schild, G. C., Sutton, R. N. P.: Inhibition of influenza virusesin vitro andin vivo by 1-adamantanamine hydrochloride. Brit. J. exp. Path.46, 263–273 (1965).

    Google Scholar 

  30. Walters, M. N.-I., Joske, R. A., Leak, P. J., Stanley, N. F.: Murine infection with reovirus. I. Pathology of the acute phase. Brit. J. exp. Path.44, 427–436 (1963).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Experimental Microbiology, Institute for Medical Microbiology, University of Zürich, Zürich, Switzerland

    O. Haller

Authors
  1. O. Haller
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

With 10 Figures

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haller, O. A mouse hepatotropic variant of influenza virus. Archives of Virology 49, 99–116 (1975). https://doi.org/10.1007/BF01317530

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01317530

Keywords

Search

Navigation